Skip to content
★ Sign in to follow
HD

Hemagen Diagnostics Inc Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by HALES WILLIAM P, was filed 01 Aug 2012.

Hemagen Diagnostics Inc: what insiders have been doing

Hemagen Diagnostics Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Hemagen Diagnostics Inc has published a filing in the past twelve months. The most recent one dates from 8 January 2013.

Looking back to 2006, when coverage begins, insiders filed 3 purchases and 1 sale.

Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
41
Thresholds
n/a
Buy Volume
€10,545
3 ops. · all time
Sell Volume
€1,241
1 ops. · all time

Financial data

· cache

US$0.00
Analyst consensus
·
Income statement
EBITDA-US$273.7k
Valuation
Beta1053.34
Profitability & ownership
ROA-10.3%
% institutions0.0%
Last declaration on 8 January 2013
Declarations41 total
  • ◆
    DirectorExecutives
    0SEC
    7,500 shares0Common StockSEC:0001140361-13-001397:0
  • ◆
    DirectorExecutives
    0SEC
    7,500 shares0Common StockSEC:0001140361-13-001396:0
  • ▲
    Chairman, President & CEOExecutives
    259 USD0SEC
    10,800 shares@ US$0.024Common StockSEC:0001140361-12-034551:0
    Canonical exit: 29 Oct 2012 (T+90)
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-12-021679:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-12-021678:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-12-002434:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-12-002436:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-11-049010:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-11-049011:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-11-036731:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-11-036732:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-11-023651:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-11-023648:0
  • ▲
    Chairman, President & CEOExecutives
    265 USD0SEC
    5,300 shares@ US$0.05Common StockSEC:0001140361-11-021388:0
    Canonical exit: 5 Jul 2011 (T+90)
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-11-011090:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-11-011091:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-10-040819:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-10-040818:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-10-028658:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-10-028657:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-10-016770:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-10-016768:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-10-001192:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-10-001191:0
  • ◆
    DirectorExecutives
    0SEC
    2,500 shares0Common StockSEC:0001140361-09-022796:0

25 of 41 declarations

About Hemagen Diagnostics Inc

Hemagen Diagnostics Inc is a company focused on developing diagnostic tests for diseases. It is listed on NASDAQ under the symbol XNAS.